Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy

HOME | CONTACT | PATIENT LOGIN | CLINIC LOGIN | FAQ

Please choose the site that is most convenient for you

Study Name: Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
8 locations found

Dana-Farber Cancer Institute
Location: Boston, Massachusetts 02115
Beth-Israel Deaconess Medical Center
Location: Boston, Massachusetts 02115
Cancer Institute of New Jersey
Location: New Brunswick, New Jersey 08901
Memorial Sloan-Kettering Cancer Center
Location: New York, New York 10065
Johns Hopkins University
Location: Baltimore, Maryland 21205
Karmanos Cancer Institute
Location: Detroit, Michigan 48201
University of Wisconsin Carbone Cancer Center
Location: Madison, Wisconsin 53792
The University of Texas M D Anderson Cancer Center
Location: Houston, Texas 77030

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.

ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.